Nanog signaling in cancer promotes stem-like phenotype and immune evasion - Wikidata - awgldk - TriplyDB

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

http://www.wikidata.org/entity/Q36357895

about

Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes The Role of microRNAs in Stemness of Cancer Stem Cells Therapeutic targeting of replicative immortality Stem Cell-Derived Extracellular Vesicles and Immune-Modulation MicroRNAs targeting prostate cancer stem cells Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer Causes of genome instability: the effect of low dose chemical exposures in modern society Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers Emerging role of nanog in tumorigenesis and cancer stem cells.RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses.A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.High glutathione and glutathione peroxidase-2 levels mediate cell-type-specific DNA damage protection in human induced pluripotent stem cells The role of Nanog expression in tamoxifen-resistant breast cancer cells Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo.Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.Targeting cancer stem cells: emerging role of Nanog transcription factor In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer.Using induced pluripotent stem cells as a tool for modelling carcinogenesis.Stem cell transcription factor NANOG in cancers--is eternal youth a curse?Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter.Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.Inhibition of NANOG/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

P2860

Q23921936-C30BCD3D-89F6-4595-9E42-8C2CF7C75FBA Q27005618-7D700D2F-2C7E-43BF-9B93-FA54C39C1044 Q27027457-7B1E4EFA-2F4A-45DF-9640-50B4F3AC7076 Q28069239-4A65166C-AA68-4DE4-BF88-AB9B8732D4CD Q28081039-B8BC7306-663A-4104-8FB5-38EEF6BD2132 Q28085029-1C21955D-54F7-4BE7-8FCD-BB531B16B596 Q28088370-FABDC6F4-BD4B-4132-BC9F-6B25F495C30C Q28296853-C5D97321-7899-4D67-853C-4D27872656C6 Q28388277-7AF40EA3-52AF-473F-82D9-899A1AB7F475 Q28540510-3B320B23-E4F2-4219-AFD9-B83D7B83EEB7 Q33702231-F1216DBC-C876-4047-BB87-D60C47382031 Q33728894-F619E6DB-CC6D-42C1-90FC-8ECDC8829EF2 Q33786554-CBD80FD9-A0D8-4616-9B30-537F4B385A88 Q33816240-86E40ABC-5CE8-46CF-B96F-7BC7610CDA86 Q33889053-DB042A91-AF4D-4328-98C1-AB95EAE42AF6 Q35082617-20F9F4C1-FDB9-4CB2-A66B-0FE142BCC345 Q35176075-6A7E87D3-FE1A-4605-B332-17D3C332C2BD Q35386974-06EF7920-A929-492A-A5BD-472B7523AE2C Q35623892-F430D0E3-57BC-4320-B723-2DC2EF487920 Q35703398-C45A1F7C-26E8-42E3-8C63-EA90EA744332 Q35878793-FA2D5265-A236-444D-9177-198FDC14C4A5 Q36134837-510A5D61-C858-46B8-9989-BDD126CC6E84 Q36545592-7906908E-4049-4AE6-9460-E9D76FC3669C Q36629387-B4583B3C-3B62-44AC-8B0E-3141F85151EA Q36729529-1D2B5208-3D4F-43C1-A975-DFD56320DE09 Q37075277-1845C4FD-623B-4C0D-A1DA-CE50621A0986 Q37170030-766E359B-8FC8-4E2C-B6C9-1997459116F4 Q37344789-5D3307DC-471D-4D17-B919-DDF0CB7E6899 Q37421084-38054D74-A1C2-48E2-BD38-4791554F3B5E Q37627441-8D17190D-531D-4D3B-973F-44FD8379A310 Q37687811-679B8A55-0570-42FA-928F-1A704D449F09 Q37744916-960EA102-625B-4509-92CB-E42F6FEF44B3 Q38170150-93BAE6FD-BCC0-4B9F-814F-E5E9AE071849 Q38212602-4DEEC919-D833-4E50-9865-1EABB0232CA9 Q38393195-F86B97D1-B5FE-4B98-B75D-288B0A7B08BE Q38658623-418E3379-6AD4-4B36-82B3-FCBBDA44E6FE Q38721023-FF1201A1-BF08-4969-965B-08CF7ADE4A05 Q38841880-F4B67D4A-45D9-4C02-8127-C04EE4267E61 Q38957684-77E84733-D101-4FC8-B611-5E71CA8FF806 Q39070920-CAC563AB-0BAC-4747-891E-E7171A8460BC

P2860

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

http://www.wikidata.org/entity/Q36357895

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@ast

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@en

type

label

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@ast

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@en

prefLabel

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@ast

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@en

P1433

Q36357895-C7D77CFD-5681-42B6-A64D-67B41B97701A

P1476

Q36357895-9F020A0A-516B-4C40-B5CB-69825571C7DC

P2093

Q36357895-0C858016-B652-4D0A-9793-850448D9B739

Q36357895-2FAEE9FF-BC99-435D-8334-55C9E38E47C5

Q36357895-461200E1-930B-4A99-8D13-544B11B69170

Q36357895-84F46048-2396-42E4-847B-D7EB26E335B4

Q36357895-8FEE0ABB-7EEE-4C48-B12A-55D49E66FBD1

Q36357895-924F273D-0DB3-4830-963F-44FB2AE24EB9

Q36357895-C069BDB6-6314-4EBB-B78A-FCFC65F544AB

Q36357895-E18CB16B-8AF4-4726-99DC-B54D03E8E3C7

Q36357895-F22E66C1-F7DB-473E-8799-5E0C014B2483

P2860

Q36357895-04379661-F527-4383-AC18-D323C383D787

Q36357895-0ED94E8C-773A-4ADC-A6BE-1176421B9B77

Q36357895-0EFCEBD6-8C15-4B91-98B5-8F09D8C80C73

Q36357895-1E6DB4C7-E2DF-4AB0-B06C-88FB3FE9A886

Q36357895-26712C1B-2087-43D4-95F9-3DA01401EAEC

Q36357895-2B761C6F-8A3C-4F6D-8EEF-A377CA521B66

Q36357895-3249E95E-0088-4174-A4B3-2F7E67E5010B

Q36357895-3D7E0BBD-AAD1-42E7-A756-02E6DC323176

Q36357895-3E104FFB-CCA5-4EEC-AED6-C94B3ECD1F71

Q36357895-407152D9-5AAA-4BD4-9CD5-B376F762CD54

P304

Q36357895-789A84CD-F17E-4B07-9A71-CFB185F4EA3B

P31

Q36357895-1FD21FAA-C580-48BD-AC20-6186562AD7D3

P356

Q36357895-F61F5DC9-2CB1-4C3E-97BC-982C89EB65C1

P407

Q36357895-C1A32DC1-DD36-414C-8811-A15620340325

P433

Q36357895-257EC05C-C27A-4C81-A95D-C4A157B48D3C

P478

Q36357895-A32E6E42-BE01-40D3-BF3D-4D13C5F26870

P50

Q36357895-38F44448-B06C-4203-B63D-3B826D047E97

Q36357895-54AC0AF4-0C4F-4DFF-88AF-F028C10BB7FC

Q36357895-BD101CA7-B82F-490D-A50C-32FAB5C97F8A

Q36357895-F09B8FCD-9225-42FD-B5D2-9FA0D6AC457A

P577

Q36357895-FCB7DD3F-8ACE-4492-99C8-49C96CCAD73C

P5875

Q36357895-041DC33B-30F9-4EDA-8AC2-3D2B67A7854D

P698

Q36357895-004C24CD-204D-4DC4-A2F1-29E3861DA09E

P932

Q36357895-A429BE59-1D77-4541-962A-4B4C63D695C8

P356

P1433

Journal of Clinical Investigation

P1476

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

@en

P2093

Bo Wook Kim

http://www.w3.org/2001/XMLSchema#string

Chih-Ping Mao

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Jin Hee Kim

http://www.w3.org/2001/XMLSchema#string

Kwon-Ho Song

http://www.w3.org/2001/XMLSchema#string

Kyung Hee Noh

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Tae Woo Kim

http://www.w3.org/2001/XMLSchema#string

Young-Ho Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

Cancer statistics, 2012

Identification of a putative transactivation domain in human Nanog

Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Tumour stem cells and drug resistance

Cancer stem cells: models and concepts

P304

4077-4093

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI64057

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Stephen M. Hewitt

Joon-Yong Chung

Seung-Yong Seong

P577

2012-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232649320

http://www.w3.org/2001/XMLSchema#string

P698

23093782

http://www.w3.org/2001/XMLSchema#string

P932

3484451

http://www.w3.org/2001/XMLSchema#string